Pathway
|
Toll-like Receptors Act through MYD88-TIRAP Signaling
|
|
NOD-like Receptors
|
|
Antiviral Signaling through Pattern Recognition Receptors
|
|
Toll-like Receptors Act through MYD88 Signaling
|
|
TLR4 Signaling in Leukocytes
|
|
Th1-Cell Differentiation
|
|
Treg-Cell Differentiation
|
|
Th2-Cell Differentiation
|
|
T-Cell Receptor Signaling
|
|
CXC Chemokine Receptor Signaling
|
|
CC Chemokine Receptor Signaling
|
|
Proplatelet Maturation
|
|
Toll-like Receptors in Sterile Inflammation
|
|
Hypothalamic-Pituitary-Adrenal Axis in Acute Phase Response
|
|
MC1R in anti-Inflammatory Signaling
|
|
Lipids Enhance Apoptotic Cell Engulfment and Reduce Inflammation
|
|
Basophil Activation
|
|
Eosinophil Survival by Cytokine Signaling
|
|
Eosinophil Activation
|
|
Mast-Cell Activation via IgE Signaling
|
|
Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling
|
|
Negative Acute Phase Proteins Synthesis
|
|
Positive Acute Phase Proteins Synthesis
|
|
Vascular Endothelial Cell Activation by Cytokines
|
|
Vascular Endothelial Cell Activation by Growth Factors
|
|
Tight Junction Assembly (Claudins)
|
|
Cardiomyocyte Dysfunction
|
|
Scavenger Receptor OLR1 in Inflammation Related Endothelial Dysfunction
|
|
Th1-Cells Activation and Proliferation in Atherosclerosis
|
|
Dilated Cardiomyopathy
|
|
Toll-like Receptors (TLR) in Antiviral Innate Immune Response
|
|
Androgens in Sebocyte Maturation
|
|
Atopic Dermatitis Onset
|
|
Acute Phase in Atopic Dermatitis
|
|
Atopic Dermatitis
|
|
Dendritic Cells Function in Psoriasis
|
|
Dendritic Cell Activation in Systemic Lupus Erythematosis
|
|
Th1-Cell Function in Systemic Lupus Erythematosus
|
|
Th2-Cell Function in Systemic Lupus Erythematosus
|
|
T-Cell Cytotoxic Response against Melanocytes in Vitiligo
|
|
Treg-Cell Function in Diabetes Mellitus Type 1
|
|
Natural Killer T-Cell Roles in Diabetes Mellitus Type 1
|
|
non-Suppressive Treg-Cell in Diabetes Mellitus Type 1
|
|
TLR2 Signaling in Treg-Cell in Type 1 Diabetes (Animal Model)
|
|
Treg-Cell Activation in Diabetes Mellitus
|
|
Bone Remodeling in Hyperthyroidism
|
|
Hypothyroidism, Secondary (Central)
|
|
Thyroid Stimulating Hormone (TSH) Resistance in Congenital Hypothyroidism
|
|
Overt Hypothyroidism, Primary
|
|
Thyroid Stimulating Hormone (TSH) Secretion in Overt Hypothyroidism
|
|
Central Hypothyroidism
|
|
Tertiary Hypothyroidism
|
|
CD4+T-Cell Response in Celiac Disease
|
|
Celiac Disease
|
|
Metastatic Colorectal Cancer
|
|
Dendritic Cell Function in Ulcerative Colitis
|
|
Th2-Cell Function in Ulcerative Colitis
|
|
Hodgkin and Reed-Sternberg Cells in Hodgkin Lymphoma
|
|
Hodgkin Lymphoma
|
|
IgE Induces Airway Smooth Muscle Cell Proliferation
|
|
Goblet-Cell Related Mucus Secretion in Asthma
|
|
Basophil Activation in Asthma
|
|
Mast-Cell Activation in Asthma
|
|
Th2-Cell Response in Asthma
|
|
Mucin Production in Goblet Airway Epithelial Cells
|
|
CFTR Facilitates Oxidative Stress in Airway Epithelium in CF
|
|
Airway Epithelial Cell Dysfunction
|
|
Dendritic Cell Dysfunction in Psoriatic Arthritis
|
|
Th2-Cells Function in Systemic Scleroderma
|
|
CD4+ T-Cell Function Decline in HIV
|
|
CD4+ T-Cell Death in HIV
|
|
Gluten Impact on Neuronal System (Hypothesis)
|
|
Prostate Cancer
|
|
Cytokines Trigger Otitis Media
|
|
MUC5AC Expression by NTHi and S. Pneumoniae
|
|
Immune System Role in Otitis Media
|
|
VEGFA High Expression Level in Pulmonary Emphysema
|
|
Mucin Hyperproduction in Goblet and Mucous Cells
|
|
S100B Expression Targets
|
|
AREG -> AP-1 Expression Targets
|
|
Noradrenaline/Gs Expression Targets
|
|
Dopamine/Gs Expression Targets
|
|
Noreadrenaline/Gq Expression Targets
|
|
Epinephrine/Gs Expression Targets
|
|
Acetylcholine Expression Targets
|
|
Serotonin/Gq Expression Targets
|
|
Epinephrine/Gq Expression Targets
|
|
Dopamine/Gi Expression Targets
|
|
BMP6/ACVR2A Expression Targets
|
|
BMP2/BMPR2 Expression Targets
|
|
BMP4/BMPR2 Expression Targets
|
|
BMP15/BMPR2 Expression Targets
|
|
BMP7/BMPR2/ACVR2 Expression Targets
|
|
Sialophorin -> CTNNB/MYC/TP53 Signaling
|
|
CD19 Expression Targets
|
|
FCGR3A Expression Targets
|
|
CD72 -> CREB/CREBBP Expression Targets
|
|
CD8 -> ATF/CREB/CREBBP Expression Targets
|
|
CD80 -> NF-kB Expression Targets
|
|
CD86 -> NF-kB Expression Targets
|
|
CTF1 Expression Targets
|
|
CXCL12 Expression Targets
|
|
CSF2 -> STAT Expression Targets
|
|
Complement Component GPCRs Signaling
|
|
LIF Expression Targets
|
|
Tamoxifen Induced Endometrial Cancer
|
|
Cyclosporine Induced Nephrotoxicity
|
|
EGF -> CTNN Expression Targets
|
|
EGF -> AP-1/ATF Expression Targets
|
|
EGF -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
EGF -> MEF/MYOD/NFATC Expression Targets
|
|
EGF -> STAT Expression Targets
|
|
EREG -> AP-1/ATF Expression Targets
|
|
Erythropoietin -> NF-kB Expression Targets
|
|
Erythropoietin -> AP-1/MYC/CREB Expression Targets
|
|
Erythropoietin -> STAT Expression Targets
|
|
Erythropoietin -> ELK/SRF Expression Targets
|
|
F2 -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
F2 -> STAT1/NF-kB Expression Targets
|
|
PLG -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
FGF9 -> AP-1/CREB/MYC Expression Targets
|
|
FGF10 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF2 -> STAT Expression Targets
|
|
FGF1 -> AP-1/CREB/ELK/SRF/MYC Expression Targets
|
|
FGF8 -> AP-1/CREB/MYC Expression Targets
|
|
FGF18 -> STAT Expression Targets
|
|
FGF18 -> AP-1/CREB Expression Targets
|
|
FGF1 -> STAT Expression Targets
|
|
FGF4 -> AP-1/MYC Expression Targets
|
|
FGF7 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF2 -> AP-1/CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
GCG Expression Targets
|
|
ADCYAP1 Expression Targets
|
|
FSHR Expression Targets
|
|
Glutamate/Gq Expression Targets
|
|
VIP Expression Targets
|
|
GH1/GHR -> NF-kB/ELK/SRF/MYC Expression Targets
|
|
GH1/GHR -> STAT Expression Targets
|
|
GH1/PRLR Expression Targets
|
|
HBEGF -> AP-1/ATF Expression Targets
|
|
HGF -> STAT Expression Targets
|
|
HGF -> AP-1/CREB/ELK/SRF/MYC Expression Targets
|
|
IGF1 -> MEF/MYOD/MYOG Expression Targets
|
|
IGF1 -> STAT Expression Targets
|
|
IGF1 -> ELK/SRF/HIF1A/MYC/SREBF Expression Targets
|
|
INHBA/ACVR2/BMPR Expression Targets
|
|
Insulin -> STAT Expression Targets
|
|
Insulin -> CEBPA/CTNNB/FOXA/FOXO Expression Targets
|
|
Insulin -> MEF/MYOD Expression Targets
|
|
Insulin -> ELK/SRF/HIF1A/MYC/SREBF Expression Targets
|
|
CTGF -> AP-1/CREB/MYC Expression Targets
|
|
ICAM1 Expression Targets
|
|
IFNG/IFNR Expression Targets
|
|
IL7 Expression Targets
|
|
IL13 Expression Targets
|
|
IL16 -> AP-1 Expression Targets
|
|
IL3 Expression Targets
|
|
IL6 Expression Targets
|
|
IL2 Expression Targets
|
|
Leptin -> STAT Expression Targets
|
|
Leptin -> ELK/SRF Expression Targets
|
|
Prostaglandin F Expression Targets
|
|
Thromboxane A2 Expression Targets
|
|
LPA Expression Targets
|
|
PAF/Gq -> AP-1/ATF1/CREB/ERK/SRF Expression Targets
|
|
Dronabinol/Anandamide Expression Targets
|
|
Morphine Expression Targets
|
|
S1P Expression Targets
|
|
PGE1 Expression Targets
|
|
NRG1 -> EP300/ETS/ETV/SP1 Expression Targets
|
|
NRG1 -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
NRG1/Catenin Expression Targets
|
|
NRG1 -> STAT Expression Targets
|
|
NRG1 -> AP-1/ATF Expression Targets
|
|
NGF -> SMAD3/NF-kB Expression Targets
|
|
NGF -> AP-1/TP53/MYC Expression Targets
|
|
BDNF Expression Targets
|
|
NTF3 Expression Targets
|
|
NTF4 Expression Targets
|
|
Adenosine Expression Targets
|
|
PDGFD -> AP-1 Expression Targets
|
|
PDGF -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PDGF -> STAT Expression Targets
|
|
AVP/Gs -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
GNRH1 Expression Targets
|
|
NTS Expression Targets
|
|
GAST Expression Targets in GAST Expression Targets
|
|
GNRH2 Expression Targets
|
|
OXT Expression Targets
|
|
POMC Expression Targets
|
|
CCL11 Expression Targets
|
|
EDN1 Expression Targets
|
|
AGT -> CREB Expression Targets
|
|
NPY Expression Targets
|
|
AVP/Gq -> STAT Expression Targets
|
|
TAC1 Expression Targets
|
|
AVP/Gs -> STAT Expression Targets
|
|
EDN3 Expression Targets
|
|
AGT -> STAT Expression Targets
|
|
AVP/Gq -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
PRL/PRLR Expression Targets
|
|
PRL/GHR -> STAT Expression Targets
|
|
PRL/GHR -> NF/kB/ELK/SRF/MYC Expression Targets
|
|
PDCD1 -> AP-1 Expression Targets
|
|
CSF1 -> STAT Expression Targets
|
|
GAS6 -> AP-1/CREB Expression Targets
|
|
KITLG -> STAT Expression Targets
|
|
KITLG -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
GDNF -> HSF1 Expression Targets
|
|
PAF Expression Targets
|
|
CSF1 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PGF -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FLT3LG -> AP-1/CREB/CREBBP Expression Targets
|
|
TGFBR1/AP-1 Signaling
|
|
MSTN/ACVR2/BMPR Expression Targets
|
|
Androgen Receptor non-Genomic Signaling
|
|
P38 MAPK/MAPK14 Signaling
|
|
TCR -> AP-1 Expression Targets
|
|
T-Cell Receptor -> AP-1 Signaling
|
|
TGFA -> STAT Expression Targets
|
|
TGFA -> CTNNB/CTNND Expression Targets
|
|
TGFA/AP-1/ATF Expression Targets
|
|
TGFA -> CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
TGFB3-TGFBR2 Expression Targets
|
|
TGFB2-TGFBR2 Expression Targets
|
|
TGFB1-TGFBR2 Expression Targets
|
|
TGFB1-TGFBR1/AP-1 Expression Targets
|
|
TGFB1-ACVRL1 Expression Targets
|
|
FASLG Expression Targets
|
|
TNFSF10 Expression Targets
|
|
LTA Expression Targets
|
|
TNFSF14 Expression Targets
|
|
TNF -> AP-1 Expression Targets
|
|
CD72 -> AP-1 Expression Targets
|
|
TNFSF13B Expression Targets
|
|
EDA Expression Targets
|
|
Thrombopoietin -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
TLR4 -> AP-1 Expression Targets
|
|
TLR5 Expression Targets
|
|
TLR7 Expression Targets
|
|
IL1B -> NO Expression Targets
|
|
TLR4 -> AP-1/EGR1/HIF1A Expression Targets
|
|
IL1B -> PGE2 Expression Targets
|
|
TLR1 -> 2/6 Expression Targets
|
|
IL1B Expression Targets
|
|
IL1A Expression Targets
|
|
TLR9 Expression Targets
|
|
ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy
|
|
PLAU -> STAT1 Expression Targets
|
|
PLAU -> ELK-SRF/AP-1 Expression Targets
|
|
VEGFA -> ATF/CREB/ELK-SRF Expression Targets
|
|
VEGFA -> STAT Expression Targets
|
|
VEGFA -> AP-1/CREBBP/MYC Expression Targets
|
|
VEGFA -> CTNNB/CTNND Expression Targets
|
|
WNT1 Expression Targets
|
|
WNT3A Expression Targets
|
|
WNT5A Expression Targets
|
|
WNT7A Expression Targets
|
|
ace2
|
|
cypa
|
|
prarg negative regulators, ps-positive
|
|
Neighbors of Jun/Fos
|
|
Model of PPARG signaling in psoriasis
|
|
PPARG negative regulators and targets
|
|
Model of PPARG related pathways in psoriasis (short version)
|
|
non-proteinal partners of SARSs
|
|
dsRNA induces innate immunity and INFs in alveolar cells
|
|
Innate immunity in Leukocytes
|
|
AGER feed forward loop in innate immunity
|
|
Dendritic Cell Activation in COVID19
|
|
2_Acute phase initiation in atopic dermatitis
|
|
1_The onset of atopic dermatitis
|
|
1_Insufficient activation of immune response in the middle ear epithelium cells in otitis media
|
|
2_Oxidized LDL causes endothelial dysfunction in atherosclerosis
|
|
3_Cardiomyocyte dysfunction unrelated to cell junctions in ARVD
|
|
1_CD4+ T cell and epithelial cell response in celiac disease
|
|
Model of PPARG signaling in psoriais (tested)
|